-
-
-
-
-
-
-
Macquarie Downgrades Dr. Reddy's Laboratories (DRRD:IN) (RDY) to Neutral
-
-
-
-
-
-
-
Dr. Reddy’s Q3 & 9MFY25 Financial Results
-
-
-
-
-
-
-
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) Misses Q1 EPS by 89c
-
-
-
-
-
-
-
Credit Suisse Downgrades Dr. Reddy\\\'s Laboratories Ltd. (DRRD:IN) (RDY) to Neutral, Following Earnings
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Announces Settlement of U.S. Patent Litigation for REVLIMID With Dr. Reddy’s (RDY)
-
-
-
-
-
-
-
Dr. Reddy’s Q2 & H1 FY20 Financial Results
-
1,210,252 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

